
    
      This study involves 2 age groups (based on primary study):

      Subjects enrolled in the >= 65 yrs age group in the primary study. Subjects enrolled in the
      18-40 yrs age group in the primary study. The study will be conducted in an open manner for
      this age group.

      The Protocol Posting has been updated in order to comply with the FDA Amendment Act, Sep
      2007.
    
  